Article (Scientific journals)
LA CURIETHÉRAPIE: un atout majeur dans le traitement du cancer du col de l’utérus localement avancé
Pleyers, Clémence
2024In Revue Médicale de Liège, 79 (5), p. 40 - 44
Editorial Reviewed verified by ORBi
 

Files


Full Text
C-Pleyers_2024_5_la-curietherapie-un-atout-majeur-dans-le-traitem_0.pdf
Publisher postprint (584.3 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Brachytherapy; Locally advanced cervical cancer; Radiotherapy; Female; Humans; Neoplasm Staging; Uterine Cervical Neoplasms; Medicine (all)
Abstract :
[en] Cervical cancer is the 4th most diagnosed cancer in women. At a locally advanced stage, standard treatment combines chemotherapy, radiotherapy and a brachytherapy boost. Brachytherapy is a radiotherapy modality, often unknown, which allows the delivery of a very targeted high dose because it’s given directly in contact with the tumor. This technique has proven its effectiveness in the treatment of locally advanced cervical cancer. It represents a major advantage because, despite technical advances, there is currently no alternative yielding equivalent results.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Pleyers, Clémence ;  Service de Radiothérapie, CHU, Liège, Belgium
Language :
French
Title :
LA CURIETHÉRAPIE: un atout majeur dans le traitement du cancer du col de l’utérus localement avancé
Alternative titles :
[en] Brachytherapy : a crucial part of locally advanced cervical cancer treatment
Publication date :
2024
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Revue Medicale de Liege
Volume :
79
Issue :
5
Pages :
40 - 44
Peer reviewed :
Editorial Reviewed verified by ORBi
Available on ORBi :
since 10 July 2025

Statistics


Number of views
32 (0 by ULiège)
Number of downloads
16 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi